Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06397118 · ClinicalTrials.gov registry record · NA
Prevention of Malnutrition in Children With Sickle Cell Disease
A NA study of Sickle Cell Disease and Malnutrition, sponsored by Vanderbilt University Medical Center.
- Active
- Registry status
- NA
- Development phase
- 148
- Enrollment target
- 1
- Study location
NCT06397118: Active NA study of Sickle Cell Disease and Malnutrition, sponsored by Vanderbilt University Medical Center.
NCT06397118 is a NA study of Sickle Cell Disease and Malnutrition that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 148 participants, below the 292-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06397118, a NA study of Sickle Cell Disease and Malnutrition, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are studying how to prevent malnutrition in children with sickle cell disease (SCD) in northern Nigeria. Community health workers will teach mothers about nutritious local foods that might help children grow better than the usual advice from doctors. The investigators will enroll 148 children with SCD aged 6 to 18 months old. The investigators will determine if their weight and diet improve and check for low vitamin A levels. This information will help us find better ways to improve growth for children with SCD.
Primary Outcome
Mean change in weight-for-age z score in the randomly allocated groups, standard care versus the novel maternal intervention. This is a continuous outcome where a higher z-score indicates a positive outcome.
Conditions Studied
Interventions
- BEHAVIORAL Standard Care
- BEHAVIORAL Maternal Nutrition Education
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2024-11-06 |
| Est. Completion | 2027-05-31 |
| Phase | NA |
What the registry record for NCT06397118 still lists
NCT06397118 is an interventional study that assigns participants to a tested intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, below the 292-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (49% lower).
The record links to 2 conditions, with Sickle Cell Disease appearing as the primary indexed condition, and to 2 interventions - of which Standard Care is the first listed.
NCT06397118 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT06397118 about?
NCT06397118 is a clinical study titled "Prevention of Malnutrition in Children With Sickle Cell Disease". The investigators are studying how to prevent malnutrition in children with sickle cell disease (SCD) in northern Nigeria. Community health workers will teach mothers about nutritious local foods that might help children grow better than the usual advice from doctors. The investigators will enroll 1...
What is the current status of trial NCT06397118?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 148 participants. The study started on 2024-11-06. Estimated completion is 2027-05-31.
What conditions does trial NCT06397118 study?
This clinical trial studies the following conditions: Sickle Cell Disease, Malnutrition.
What interventions are being tested in trial NCT06397118?
The interventions under investigation include: Standard Care (BEHAVIORAL), Maternal Nutrition Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT06397118?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06397118 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sickle Cell Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06397118's enrollment target sits among peer trials
148 45th of 213 higher than 169 of 213 other Sickle Cell Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sickle Cell Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
Exercise in Child Health
RECRUITING · NA
-
Sickle Cell Children's Exercise Study (SuCCESs)
RECRUITING · NA
-
Cutaneous Hydration Assessment in SCD
RECRUITING · NA
-
MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI